Publications Database

Mohiuddin S. , Ghaziuddin M. (2013)

Psychopharmacology of autism spectrum disorders: A selective review.

Autism

17(6), pp. 645-654.

Read Abstract (New Window)

Murray M. et al. (2014)

Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care.

Psychopharmacology (Berl)

231(6), pp. 1011-1021.

Read Abstract (New Window)

National Institute for Health and Clinical Excellence (2000)

Guidance on the use of methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood: Information for patients.

London: National Institute for Health and Clinical Excellence

National Institute for Health and Clinical Excellence (2000)

Methylphenidate, atomoxetine and dexamfetamine for the treatment of attention deficit hyperactivity disorder in children and adolescents (including a review of guidance TA13)

London: National Institute for Health and Clinical Excellence

Read Full (New Window)

Nickels K. et al. (2008)

Stimulant medication treatment of target behaviors in children with autism: a population-based study.

Journal of Developmental and Behavioral Pediatrics

29(2), pp. 75-81

Read Abstract (New Window) Read Full (New Window)

Oswald D. P. , Sonenklar N. A. (2007)

Medication use among children with autism spectrum disorders.

Journal of Child and Adolescent Psychopharmacology

17(3), pp. 348-355

Read Abstract (New Window)

Parikh M. , Kolevzon A. , Hollander E. (2008)

Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability

Journal of Child and Adolescent Psychopharmacology

April, 18(2), pp. 157-178

Read Abstract (New Window)

Peñagarikan O. (2014)

New therapeutic options for autism spectrum disorder: Experimental evidences.

Experimental Neurobiology

December, 24(4), pp. 301-311.

Read Abstract (New Window) Read Full (New Window)

Pearson D. A. et al. (2013)

Effects of extended release methylphenidate treatment on ratings of attention-deficit hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.

Journal of Child and Adolescent Psychopharmacology

23(5), pp. 337-351.

Read Abstract (New Window) Read Full (New Window)

American Society of Health-System Pharmacists (2007)

Dextroamphetamine.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

Politte L. C. , Henry C. A. , McDougle C. J. (2014)

Psychopharmacological interventions in autism spectrum disorder.

Harvard Review of Psychiatry

22(2), pp. 76-92.

Read Abstract (New Window)

Posey D. J. , McDougle C. J. (2001)

Pharmacotherapeutic management of autism.

Expert Opinion on Pharmacotherapy

2(4), pp. 587-600

Read Abstract (New Window)

Posey D. J. et al. (2007)

Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.

Biological Psychiatry

61(4), pp. 538-544.

Read Full (New Window)

Posey D. J. , McDougle C. J. (2000)

The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.

Harvard Review of Psychiatry

8(2), pp. 45-63

Read Abstract (New Window)

Quintana H. et al. (1995)

Use of methylphenidate in the treatment of children with autistic disorder.

Journal of Autism and Developmental Disorders

25(3), pp. 283-294

Read Abstract (New Window)

Realmuto G. , August G. , Garfinkel B. (1989)

Clinical effect of buspirone in autistic children.

Journal of Clinical Psychopharmacology

9(2), pp. 122-125

Read Abstract (New Window)

Reichow B. , Volkmar F. R. , Bloch M. H. (2013)

Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders.

Journal of Autism and Developmental Disorders

43(10), pp. 2435-2441.

Read Abstract (New Window) Read Full (New Window)

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network (2005)

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Archives of General Psychiatry

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network 62(11), pp. 1266-1274

Read Abstract (New Window) Read Full (New Window)

Rosenberg R. E. et al. (2010)

Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008.

Journal of Autism and Developmental Disorders

40(3), pp. 342-351.

Read Abstract (New Window)

Roy M. et al. (2009)

Effective methylphenidate treatment of an adult Aspergers syndrome and a comorbid ADHD: A clinical investigation with fMRI.

Journal of Attention Disorders

12(4), pp. 381-385

Read Abstract (New Window)